These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20188226)

  • 1. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes.
    Gooi JH; Pompolo S; Karsdal MA; Kulkarni NH; Kalajzic I; McAhren SH; Han B; Onyia JE; Ho PW; Gillespie MT; Walsh NC; Chia LY; Quinn JM; Martin TJ; Sims NA
    Bone; 2010 Jun; 46(6):1486-97. PubMed ID: 20188226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in calcitonin receptor expression in osteocytes with age.
    Gooi JH; Chia LY; Walsh NC; Karsdal MA; Quinn JM; Martin TJ; Sims NA
    J Endocrinol; 2014 May; 221(2):181-91. PubMed ID: 24516262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.
    Silvestrini G; Ballanti P; Leopizzi M; Sebastiani M; Berni S; Di Vito M; Bonucci E
    J Mol Histol; 2007 Aug; 38(4):261-9. PubMed ID: 17549589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
    Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
    Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone.
    Tamasi JA; Vasilov A; Shimizu E; Benton N; Johnson J; Bitel CL; Morrison N; Partridge NC
    J Bone Miner Res; 2013 Sep; 28(9):1975-86. PubMed ID: 23519994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
    Li F; Cain JD; Tombran-Tink J; Niyibizi C
    J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.
    Jia HB; Ma JX; Ma XL; Yu JT; Feng R; Xu LY; Wang J; Xing D; Zhu SW; Wang Y
    Osteoporos Int; 2014 Dec; 25(12):2743-54. PubMed ID: 25074352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does osteocytic SOST suppression mediate PTH bone anabolism?
    Kramer I; Keller H; Leupin O; Kneissel M
    Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation.
    Baertschi S; Baur N; Lueders-Lefevre V; Voshol J; Keller H
    J Biol Chem; 2014 Sep; 289(36):24995-5009. PubMed ID: 25012661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological function of bone cells on the PTH-driven anabolic effect].
    Hasegawa T; Hongo H; Sasaki M; Yamada T; Amizuka N
    Clin Calcium; 2012 Mar; 22(3):373-9. PubMed ID: 22370304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis.
    Kim JH; Kim AR; Choi YH; Kim A; Sohn Y; Woo GH; Cha JH; Bak EJ; Yoo YJ
    J Transl Med; 2018 Mar; 16(1):70. PubMed ID: 29544500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Sclerostin Production in Human Male Osteocytes by Androgens: Experimental and Clinical Evidence.
    Di Nisio A; De Toni L; Speltra E; Rocca MS; Taglialavoro G; Ferlin A; Foresta C
    Endocrinology; 2015 Dec; 156(12):4534-44. PubMed ID: 26393301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein.
    Gould NR; Williams KM; Joca HC; Torre OM; Lyons JS; Leser JM; Srikanth MP; Hughes M; Khairallah RJ; Feldman RA; Ward CW; Stains JP
    Elife; 2021 Mar; 10():. PubMed ID: 33779549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Association Between Sclerostin and INSL3 in Isolated Human Osteocytes and in Klinefelter Syndrome: New Hints for Testis-Bone Crosstalk.
    Di Nisio A; De Toni L; Rocca MS; Ghezzi M; Selice R; Taglialavoro G; Ferlin A; Foresta C
    J Clin Endocrinol Metab; 2018 May; 103(5):2033-2041. PubMed ID: 29452406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.